FSP1+基质细胞相关巨噬细胞胞葬作用参与子宫腺肌病蜕膜化受损
该研究基于3例子宫腺肌病分泌中期在位内膜单细胞RNA测序并整合公共数据,发现FSP1+基质细胞增多,经ZBTB7A促进GAS6分泌,与巨噬细胞MERTK作用增强胞葬,巨噬细胞分泌TNF-α致基质细胞衰老与蜕膜化缺陷。
要点
- 子宫腺肌病分泌中期FSP1+基质细胞增多,经ZBTB7A促进GAS6分泌。
- GAS6-MERTK增强巨噬细胞胞葬,TNF-α升高致基质细胞衰老。
- 靶向GAS6-MERTK-TNF-α通路或可改善蜕膜化损伤。
核心结论
- 子宫腺肌病中FSP1+基质细胞扩增可能促进GAS6相关巨噬细胞胞葬,与巨噬细胞TNF-α分泌增加及邻近基质细胞衰老相关。
- 靶向GAS6-MERTK-TNF-α通路可能为治疗子宫腺肌病蜕膜化损伤的潜在策略。
研究设计与样本
- 取3例子宫腺肌病患者分泌中期在位内膜行单细胞RNA测序,并整合公共正常内膜数据GSE183837。
- 分离原代人子宫内膜基质细胞与内膜巨噬细胞进行体外机制研究,含基因操作与功能共培养实验。
- 以M-CSF诱导外周血单核细胞来源巨噬细胞验证胞葬相关机制。
- 采用机械损伤诱导的C57BL/6小鼠子宫腺肌病模型进行体内验证。
主要发现
- 子宫腺肌病患者分泌中期在位内膜中FSP1+基质细胞丰度显著升高。
- FSP1+基质细胞通过转录因子ZBTB7A调控GAS6分泌,GAS6可能作用于巨噬细胞MERTK受体促进胞葬。
- 活化的巨噬细胞分泌TNF-α,促使基质细胞衰老,并可能促进蜕膜化缺陷。
- 蜕膜化以PRL与IGFBP1的mRNA或蛋白水平评估,衰老以SA-β-gal染色及衰老标志物/SASP谱评估。
临床怎么用
- 对子宫腺肌病内膜容受性不良者,可关注FSP1+基质细胞-巨噬细胞胞葬轴这一机制环节。
- GAS6-MERTK-TNF-α通路可作为未来改善蜕膜化缺陷的潜在干预靶点,尚需临床验证。
局限性
- 自采样本与公共数据整合、发现队列较小,可能引入偏倚。
- GSE183837对照来自因男性因素不孕行IVF的女性,可能不完全代表未助孕的生理性分泌中期内膜。
- Tamnorzatinib为AXL/MERTK双抑制剂,胞葬效应不能完全归因于MERTK信号。
- 尚需更大临床队列、基因敲除小鼠模型及人子宫内膜 assembloid 进一步验证该机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does disrupted cell crosstalk contribute to embryo implantation failure in adenomyosis, and what is the underlying molecular mechanism? SUMMARY ANSWER: Expanded Fibroblast-Specific Protein 1 (FSP1)+ stromal cell populations in adenomyosis may promote GAS6-associated macrophage efferocytosis, which correlates with increased macrophage TNF-α secretion and senescence of adjacent stromal cells. WHAT IS KNOWN ALREADY: Adenomyosis impairs endometrial receptivity and decidual transformation, contributing to implantation failure and pregnancy loss. Women with this condition exhibit increased endometrial macrophage abundance. STUDY DESIGN, SIZE, DURATION: Three mid-secretory phase eutopic endometrial samples from patients with adenomyosis were subjected to single-cell RNA sequencing (scRNA-seq) and integrated with publicly available normal endometrial scRNA-seq data (GSE183837) to characterize cellular alterations and intercellular interactions. Primary human endometrial stromal cells and endometrial macrophages were isolated for in vitro mechanistic studies, including genetic manipulation and functional co-culture assays to investigate stromal-macrophage crosstalk. Peripheral blood mononuclear cells-derived macrophages were generated by M-CSF induction to further validate efferocytosis-related mechanisms, and a mechanical injury-induced C57BL/6 mouse model of adenomyosis was employed to validate key molecular changes in vivo. PARTICIPANTS/MATERIALS, SETTING, METHODS: ScRNA-seq data were processed with Cell Ranger and Seurat for clustering and differential expression analysis, while cell-cell communication was analyzed using CellPhoneDB and CellChat. Macrophage efferocytosis was assessed by TUNEL/CD68 staining and in vitro co-culture assays. Senescence was evaluated by senescence-associated β-galactosidase staining and senescence-associated markers/senescence-associated secretory phenotype profiling, while decidualization was assessed by mRNA or protein levels of PRL and IGFBP1. Methods for mechanistic studies included adenovirus transduction, quantitative real-time PCR, western blotting, ELISA, chromatin immunoprecipitation-quantitative PCR, immunohistochemistry, immunofluorescence, and EdU staining. MAIN RESULTS AND THE ROLE OF CHANCE: Our findings revealed a significant elevation in the abundance of FSP1+ stromal cells within the eutopic endometrium of adenomyosis patients during the mid-secretory phase. These FSP1+ stromal cells orchestrated GAS6 secretion via the transcription factor ZBTB7A, and GAS6 could potentially interact with MERTK receptors on macrophages to facilitate efferocytosis. Notably, activated macrophages secreted TNF-α, which contributed to senescence in stromal cells and could promote decidualization defects that may further compromise fertility. LARGE SCALE DATA: The raw scRNA-seq data have been deposited in the NCBI Sequence under accession number PRJNA1270747. LIMITATIONS, REASONS FOR CAUTION: The integration of in-house samples with public data and the relatively small discovery cohort may have introduced bias. The control samples in GSE183837 were obtained from women undergoing IVF for male-factor infertility and may not fully represent unassisted physiological mid-secretory endometrium. Tamnorzatinib is a dual AXL/MERTK inhibitor, so the efferocytosis effects cannot be attributed solely to MERTK signaling. Further studies in larger clinical cohorts, knockout mouse models, and human endometrial assembloids are needed to substantiate the proposed mechanism. WIDER IMPLICATIONS OF THE FINDINGS: FSP1+ stromal cells play a crucial role in macrophage efferocytosis and decidualization defects. Targeting the GAS6-MERTK-TNF-α pathway may provide a potential therapeutic strategy for treating decidualization impairment in adenomyosis. FUNDING: This study was supported by the National Natural Science Foundation of China (no. 82401964, 82371678), the Natural Science Foundation of Jiangsu Province (no. BK20240224), and the Noncommunicable Chronic Diseases-National Science and Technology Major Project (no. 2023ZD0518400). DISCLOSURES: The authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Wang X, Mei J, Li R, et al. FSP1+ stromal cell-associated macrophage efferocytosis contributes to impaired decidualization in adenomyosis. Hum Reprod. 2026. PMID: 42858077. doi:10.1093/humrep/deag160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。